Eating disorders occur at high rates in adolescents with epilepsy and are associated with psychiatric comorbidities and suicidality

Abstract

Objectives

To assess the occurrence rate, characteristics, and impact of eating disorders (EDs) in adolescents with epilepsy.

Methods

In this observational study, adolescents with epilepsy seen in a single center between 2013-2022 who had comorbid EDs were compared to two control groups of adolescents with only epilepsy and only EDs. Patients with intellectual disability or autism spectrum disorder were excluded. Data retrieved included demographic and anthropometric details and clinical variables relating to seizure types, EDs, and psychiatric disorders and behaviors.

Results

A total of 376 ...

Seguir leyendo →
0

Periodic discharges plus fast activity on EEG predict worse outcomes in post‐stroke epilepsy

Abstract

Objectives

Post-seizure functional decline is a concern in post-stroke epilepsy (PSE). However, data on electroencephalogram (EEG) markers associated with functional decline are scarce. Thus, we investigated whether periodic discharges (PDs) and their specific characteristics are associated with functional decline in patients with PSE.

Methods

In this observational study, patients admitted with seizures of PSE and who had scalp EEGs were included. The association between the presence or absence of PDs and post-seizure short-term functional decline lasting 7 days after admission was investigated. In patients ...

Seguir leyendo →
0

Safety, tolerability, and efficacy of adjunctive lacosamide in pediatric patients with epilepsy syndromes associated with generalized seizures: Phase 2, open‐label exploratory trial

Abstract

Objective

To evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of lacosamide (LCM) (up to 12 mg/kg/day or 600 mg/day) as adjunctive therapy in pediatric patients with epilepsy syndromes associated with generalized seizures.

Methods

Phase 2, multicenter, open-label exploratory trial (SP0966; NCT01969851; 2012-001446-18) of oral LCM for epilepsy syndromes associated with generalized seizures in pediatric patients ≥1 month to <18 years of age taking one to three concomitant antiseizure medications. The trial comprised a 6-week prospective baseline period, 6-week flexible titration period, and 12-week maintenance period.

Results

Fifty-five patients ...

Seguir leyendo →
0

Postoperative seizure and memory outcome of temporal lobe epilepsy with hippocampal sclerosis: A systematic review

Abstract

Objective

We conducted a systematic review and meta-analysis to evaluate postoperative seizure and memory outcomes of temporal lobe epilepsy with different hippocampal sclerosis (HS) subtypes classified by ILAE Consensus Guidelines in 2013.

Method

Following the PRISMA and MOOSE guidelines, we searched PubMed, Embase, Web of Science, and Cochrane Library from January 1, 2013 to August 6, 2023. Observational studies reporting seizure and memory outcomes among different HS subtypes were included. We used the Newcastle-Ottawa scale to assess the risk of bias and the ...

Seguir leyendo →
0

Impaired cardiac modulation in patients with functional seizures: Results from a face intensity judgment task.

Abstract

Objective

While interoceptive abnormality in patients with functional seizure (FS) has been demonstrated using explicit tasks, implicit measurements of interoception such as the effect of interoception on perceptual brain processes, have not been investigated. It has been shown that perception
is
normally modulated by interoceptive signals related to the
different phases (systole v diastole) of the
cardiac cycle (cardiac modulation
effect
). Given our previous findings using ...

Seguir leyendo →
0

Sensing with deep brain stimulation device in epilepsy: aperiodic changes in thalamic local field potential during seizures

Abstract

Objective

Thalamic deep brain stimulation (DBS) is an effective therapeutic option in patients with drug-resistant epilepsy. Recent DBS devices with sensing capabilities enable chronic, outpatient local field potential (LFP) recordings. Whereas beta oscillations have been demonstrated to be a useful biomarker in movement disorders, the clinical utility of DBS sensing in epilepsy remains unclear. Our aim was to determine LFP features that distinguish ictal from inter-ictal states, which may aid in tracking seizure outcomes with DBS.

Methods

Electrophysiology data were obtained from DBS ...

Seguir leyendo →
0

The role of neuronal antibodies in cryptogenic new‐onset refractory status epilepticus

Abstract

Most cases with new-onset refractory status epilepticus (NORSE) remain cryptogenic despite extensive diagnostic work-up. The aim of this study was to analyse the etiology and clinical features of NORSE and investigate known or potentially novel autoantibodies in cryptogenic NORSE (cNORSE). We retrospectively assessed the medical records of adults with status epilepticus at a Swiss tertiary referral center between 2010 and 2021. Demographic, diagnostic, therapeutic and outcome parameters were characterized. We performed post-hoc screening for known or potentially novel autoantibodies including ...

Seguir leyendo →
0

Prophecy or empiricism? Clinical value of predicting versus determining genetic variant functions

Abstract

The recent explosion of epilepsy genetic testing has created challenges for interpretation of gene variants. Assessments of the functional consequences of genetic variants either by predictive or experimental strategies can contribute to estimating pathogenicity, but there is no consensus on which approach is best. The Special Interest Group on Epilepsy Genetics hosted a session during the Annual American Epilepsy Society Meeting in December 2022 to discuss this topic. The session featured a debate of the relative advantages and limitations of ...

Seguir leyendo →
0

Long‐term safety and efficacy of adjunctive brivaracetam in pediatric patients with epilepsy: An open‐label, follow‐up trial

Abstract

Objective

To evaluate the long-term safety, tolerability, and efficacy of adjunctive brivaracetam (BRV) treatment in pediatric patients with epilepsy.

Methods

Phase 3, open-label, multicenter, long-term follow-up trial (N01266; NCT01364597; patients aged 1 month to <17 years at core trial entry; direct enrollers aged 4 to <17 years) treated with BRV. Outcomes included treatment-emergent adverse events (TEAEs), behavior assessments (Achenbach Child Behavior Checklist [CBCL]; Behavior Rating Inventory of Executive Function [BRIEF-P/BRIEF]), and efficacy outcomes (percent change in focal seizure frequency, 50% responder rate for all seizure ...

Seguir leyendo →
0
Página 21 de 225 «...101920212223...»